| 2025 | | Digital Health Intervention Effect on Older Adults With Chronic Diseases Living Alone: Systematic Review and Meta-Analysis of Randomized Controlled Trials | 이문재 |
| 2024 | | Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Trends and levels of the global, regional, and national burden of appendicitis between 1990 and 2021: findings from the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global, regional, and national stillbirths at 20 weeks' gestation or longer in 204 countries and territories, 1990–2021: findings from the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050 | 이문재 |
| 2024 | | Forecasting the effects of smoking prevalence scenarios on years of life lost and life expectancy from 2022 to 2050: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Publisher Correction: Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global estimates on the number of people blind or visually impaired by Uncorrected Refractive Error: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global estimates on the number of people blind or visually impaired by age-related macular degeneration: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020 | 이문재 |
| 2024 | | Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | The impact of the expanded health insurance coverage policy on healthcare spending: evidence from Korea | 이문재 |
| 2024 | | Correction to: Medical expenses and its determinants in female patients with urological disorder | 이문재 |
| 2024 | | Effectiveness of artificial intelligence in detecting and managing depressive disorders: Systematic review | 이문재 |
| 2024 | | Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2024 | | The state of arts and health in the Republic of Korea | 김미란, 이문재 |
| 2024 | | Medical expenses and its determinants in female patients with urological disorder | 이문재 |
| 2024 | | Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2023 | | Global Burden of Cardiovascular Diseases and Risks, 1990-2022 | 이문재 |
| 2023 | | Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 | 이문재 |
| 2023 | | Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 | 이문재 |
| 2023 | | Analyzing the Effectiveness of Data-Linked Projects for Health Promotion in Public Health Centers of South Korea | 이문재 |
| 2023 | | Strategic management and organizational culture of medical device companies in relation to corporate performance | 박세원, 이문재 |
| 2023 | | Factors influencing the health satisfaction of users of public health and medical institutions in South Korea | 이문재 |
| 2023 | | An analytic hierarchy process analysis for reinforcing doctor–patient communication | 박세원, 이문재 |
| 2022 | | Policy network analysis the legislation process for medical privatization in Korea | 이문재 |
| 2022 | | Analyzing Community Care Research Trends Using Text Mining | 박세원, 이문재 |
| 2022 | | How to calculate the life cycle of high-risk medical devices for patient safety | 박세원, 이문재 |
| 2022 | | The usefulness of patient-specific 3D nasal silicone implant using 3D design and order form | 이문재 |
| 2022 | | Comparative Analysis of Factors Affecting Quality of Community-Based Care Services in Korea | 이문재 |
| 2022 | | Digital Health Care Industry Ecosystem: Network Analysis | 박세원, 이문재 |
| 2022 | | Factors associated with quality of life in patients with benign prostatic hyperplasia, 2009-2016 | 박세원, 이문재 |
| 2021 | | Regional Factors Influencing Non-Take-Up for Social Support in Korea Using a Spatial Regression Model | 이문재 |
| 2021 | | Factors affecting revisit intention for medical services at dental clinics | 이문재 |
| 2021 | | Innovative culture and firm performance of medical device companies: Mediating effects of investment in education and training | 이문재 |
| 2021 | | Healthy City Project: An application of data envelopment analysis | 이문재 |
